| Gabrielle Stelzer, | |
|
6907 Pawtuckett Rd, Charlotte, NC 28214-2230 | |
| (484) 947-8920 | |
| Not Available |
| Full Name | Gabrielle Stelzer |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 6907 Pawtuckett Rd, Charlotte, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013799535 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | P21524 (North Carolina) | Primary |
| Provider Name | Empowerme Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1285382440 PECOS PAC ID: 2769723162 Enrollment ID: O20220331000838 |
News Archive
A new study out of Madrid, Spain shows that low-glycemic foods, and moderately high-protein intake has been shown to reduce body weight and fat mass.
Critical Signal Technologies, Inc. (CST) has acquired the stock and assets of GTL, Inc. dba as "Link to Life" along with Link Technologies, Inc., and will integrate its product and service offerings into CST to provide cost-effective personal emergency response, TeleHealth and medical monitoring systems, improving the independence and quality of life for older adults, the disabled and people managing health conditions.
Alaska has a message for HHS Secretary Kathleen Sebelius: Don't assume that health care delivery reform can work the same way in every state. That's the lesson Sen. Mark Begich says he tried to impart to Sebelius as he toured some of the state's health and early child care centers with her last week. Sebelius went to learn first-hand about the state's health services, the Indian Health Service, and how the health law is being implemented.
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
Malfunctioning single proteins can cause disruptions in neuronal junctions leading to autistic forms of behavior. A current study, published in the scientific journal Nature, comes to this conclusion after examining genetically altered mice.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gabrielle Stelzer, 6907 Pawtuckett Rd, Charlotte, NC 28214-2230 Ph: (484) 947-8920 | Gabrielle Stelzer, 6907 Pawtuckett Rd, Charlotte, NC 28214-2230 Ph: (484) 947-8920 |
News Archive
A new study out of Madrid, Spain shows that low-glycemic foods, and moderately high-protein intake has been shown to reduce body weight and fat mass.
Critical Signal Technologies, Inc. (CST) has acquired the stock and assets of GTL, Inc. dba as "Link to Life" along with Link Technologies, Inc., and will integrate its product and service offerings into CST to provide cost-effective personal emergency response, TeleHealth and medical monitoring systems, improving the independence and quality of life for older adults, the disabled and people managing health conditions.
Alaska has a message for HHS Secretary Kathleen Sebelius: Don't assume that health care delivery reform can work the same way in every state. That's the lesson Sen. Mark Begich says he tried to impart to Sebelius as he toured some of the state's health and early child care centers with her last week. Sebelius went to learn first-hand about the state's health services, the Indian Health Service, and how the health law is being implemented.
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
Malfunctioning single proteins can cause disruptions in neuronal junctions leading to autistic forms of behavior. A current study, published in the scientific journal Nature, comes to this conclusion after examining genetically altered mice.
› Verified 1 days ago
Karan Bobby Johar, D.P.T Physical Therapist Medicare: Medicare Enrolled Practice Location: 3800 Shamrock Dr, Charlotte, NC 28215 Phone: 704-532-7000 | |
Jessica Huschart, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1100 Blythe Blvd, Charlotte, NC 28203 Phone: 704-355-2382 | |
Victoria Parish Reynolds, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 15825 Ballantyne Medical Pl Ste 120, Charlotte, NC 28277 Phone: 704-323-3409 | |
Activade Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 809 Woodruff Pl, Charlotte, NC 28208 Phone: 704-839-2019 | |
Gelt Haridhas Pushpa, Physical Therapist Medicare: Medicare Enrolled Practice Location: 445 S Kings Dr, Charlotte, NC 28204 Phone: 704-384-1737 | |
Reyna Yuritzia Fox, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3442 Cypress Club Dr, Charlotte, NC 28210 Phone: 704-714-5500 | |
Ashley F Volpenhein, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7422 Lancer Dr, Charlotte, NC 28226 Phone: 704-307-0897 |